{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:53:04Z","timestamp":1787241184700,"version":"build-2736575974"},"reference-count":30,"publisher":"Impact Journals, LLC","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2022,4,15]]},"DOI":"10.18632\/aging.204008","type":"journal-article","created":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T18:16:37Z","timestamp":1649614597000},"page":"3203-3215","source":"Crossref","is-referenced-by-count":8,"title":["Survival and prognostic analysis of T-cell lymphoblastic lymphoma patients treated with dose-adjusted BFM-90 regimen"],"prefix":"10.18632","volume":"14","author":[{"given":"Hui","family":"Yu","sequence":"first","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Mi","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Qi","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Ye","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dedao","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ding","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogan","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Song","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xie","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2022,4,10]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1309\/AJCP7YLTQPUSDQ5C","article-title":"Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification.","volume":"13","author":"Chen","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"2","first-page":"259","article-title":"[Lymphoblastic lymphoma].","volume":"2","author":"Kusakabe","year":"1998","journal-title":"Ryoikibetsu Shokogun Shirizu"},{"key":"3","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1182\/blood-2007-09-112920","article-title":"Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.","volume":"11","author":"Mann","year":"2008","journal-title":"Blood"},{"key":"4","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1200\/JCO.2001.19.11.2927","article-title":"High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation\/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group.","volume":"1","author":"Goldstone","year":"2001","journal-title":"J Clin Oncol"},{"key":"5","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1200\/JCO.2001.19.7.1935","article-title":"Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.","volume":"1","author":"Plouvier","year":"2001","journal-title":"J Clin Oncol"},{"key":"6","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1182\/blood-2002-01-0110","article-title":"Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia.","volume":"9","author":"Walewski","year":"2002","journal-title":"Blood"},{"key":"7","first-page":"1687","article-title":"[Efficacy of modified BFM-90 regimen on children and adolescents with T cell lymphoblastic lymphoma: a report of 20 cases].","volume":"2","author":"Guan","year":"2004","journal-title":"Ai Zheng"},{"key":"8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s12032-015-0551-9","article-title":"Outcomes of dose-adjusted Berlin-Frankfurt-M\u00fcnster-90 regimen without radiotherapy in adolescents and adults with T cell lymphoblastic lymphoma.","volume":"3","author":"Zhu","year":"2015","journal-title":"Med Oncol"},{"key":"9","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s00277-014-2106-0","article-title":"The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.","volume":"9","author":"Irken","year":"2014","journal-title":"Ann Hematol"},{"key":"10","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/ajh.24200","article-title":"Follicular lymphoma: 2015 update on diagnosis and management.","volume":"9","author":"Freedman","year":"2015","journal-title":"Am J Hematol"},{"key":"11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s12185-017-2355-5","article-title":"High-dose chemotherapy and autologous peripheral blood stem cell transplantation with BCVAC regimen followed by maintenance chemotherapy for children with very high risk acute lymphoblastic leukemia.","volume":"10","author":"Ahn","year":"2018","journal-title":"Int J Hematol"},{"key":"12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/jamaoncol.2018.6278","article-title":"Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation: A Consensus Project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMT.","volume":"5","author":"Inwards","year":"2019","journal-title":"JAMA Oncol"},{"key":"13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s00520-005-0792-9","article-title":"The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT--results of a randomized multicentre study.","volume":"1","author":"Misaniov\u00e1","year":"2005","journal-title":"Support Care Cancer"},{"key":"14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00277-019-03605-1","article-title":"High-dose etoposide could discriminate the benefit from autologous peripheral blood stem cell transplantation in the patients with refractory diffuse large B cell lymphoma.","volume":"9","author":"Wang","year":"2019","journal-title":"Ann Hematol"},{"key":"15","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1002\/cncr.28273","article-title":"Dynamic prognostication using conditional survival estimates.","volume":"11","author":"Panageas","year":"2013","journal-title":"Cancer"},{"key":"16","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1093\/jnci\/djaa022","article-title":"Conditional Survival, Cause-Specific Mortality, and Risk Factors of Late Mortality After Allogeneic Hematopoietic Cell Transplantation.","volume":"11","author":"Armenian","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"17","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1002\/ijc.32640","article-title":"Neutrophil-to-lymphocyte ratio and risk of lung cancer mortality in a low-risk population: A cohort study.","volume":"14","author":"Ryu","year":"2019","journal-title":"Int J Cancer"},{"key":"18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.amjsurg.2020.04.007","article-title":"Elevated neutrophil to lymphocyte ratio is associated with poor long-term survival and graft failure after lung transplantation.","volume":"22","author":"Bush","year":"2021","journal-title":"Am J Surg"},{"key":"19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40425-018-0383-1","article-title":"Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.","volume":"6","author":"Ascierto","year":"2018","journal-title":"J Immunother Cancer"},{"key":"20","doi-asserted-by":"publisher","first-page":"955","DOI":"10.2147\/OTT.S153290","article-title":"Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis.","volume":"1","author":"Sacdalan","year":"2018","journal-title":"Onco Targets Ther"},{"key":"21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3857\/roj.2019.00220","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.","volume":"3","author":"Kang","year":"2019","journal-title":"Radiat Oncol J"},{"key":"22","doi-asserted-by":"publisher","first-page":"e19877","DOI":"10.1097\/MD.0000000000019877","article-title":"High neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict poor survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy.","volume":"9","author":"Yang","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"23","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3109\/10428194.2013.828350","article-title":"Long-term outcomes of modified Berlin-Frankfurt-M\u00fcnster-90 regimen in adults with T-lymphoblastic lymphoma: a single-center experience.","volume":"5","author":"Xia","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/annonc\/mdl426","article-title":"Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes.","volume":"1","author":"Toze","year":"2007","journal-title":"Ann Oncol"},{"key":"25","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/leu.2012.311","article-title":"Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies.","volume":"2","author":"Kogut","year":"2013","journal-title":"Leukemia"},{"key":"26","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/bjh.13965","article-title":"A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma.","volume":"17","author":"Holte","year":"2016","journal-title":"Br J Haematol"},{"key":"27","doi-asserted-by":"publisher","first-page":"e190194","DOI":"10.1001\/jamanetworkopen.2019.0194","article-title":"Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer\/T-Cell Lymphoma.","volume":"2","author":"Qian","year":"2019","journal-title":"JAMA Netw Open"},{"key":"28","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1016\/j.bbmt.2019.08.012","article-title":"Comparison of High Doses of Total Body Irradiation in Myeloablative Conditioning before Hematopoietic Cell Transplantation.","volume":"2","author":"Diaz","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/bmt.2015.278","article-title":"Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT.","volume":"5","author":"Zuckerman","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"30","doi-asserted-by":"publisher","first-page":"524","DOI":"10.19746\/j.cnki.issn.1009-2137.2020.02.028","article-title":"[Efficacy and Safety of Intensive Maintenance Chemotherapy Regimen for Treatment of Children and Adolescents with Lymphoblastic Lymphoma for Stage III-IV].","volume":"2","author":"Sun","year":"2020","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T22:11:07Z","timestamp":1650492667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,10]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,4,15]]}},"alternative-id":["204008","35400665"],"URL":"https:\/\/doi.org\/10.18632\/aging.204008","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,10]]}}}